Efficacy of Ankle Foot Orthosis on Multiple Sclerosis

Investigating the efficacy of new arthiculated AFO on biomechanical parameters in gait of multiple sclerosis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190919044818N2

Enrollment

Registered

2023-03-19

Start date

2023-05-05

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis. Multiple Sclerosis

Interventions

Intervention group: Newly designed spring damper Ankle Foot Orthosis.

Eligibility

Sex/Gender

All

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: At least 6 months after diagnosed with MS Extended disability scale between 4 to 6 Unilateral drop foot Endurance to ambulate at least 30 feet continuously with minimal assist without the use of an AFO The maximum spasticity of grade II with plantar flexor muscles according ti Ashworth scale

Exclusion criteria

Exclusion criteria: Significant cardiac or respiratory disease Musculoskeletal impairments and/or pain that severely limited walking Fixed flexion contracture or spasticity of the hip, knee and ankle joints History of surgery, trauma, and fracture in lower limbs

Design outcomes

Primary

Measure	Time frame
Biomechanical parameters (spatiotemporal, kinematic and kinetic). Timepoint: Before intervention and after intervention. Method of measurement: Motion analysis system and force plate.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEnsieh Pourhoseingholi

Hamedan University of Medical Sciences

ensiehpmd@yahoo.com+98 21 4480 3255

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026